Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
←Back to story

US FDA Proposes to Withdraw Approval for Salerno's Cholesterol Medication

MedscapeView source article

Part of story

FDA proposes to withdraw approval for Salerno's liquid cholesterol medication

The FDA's drug evaluation department proposed withdrawing approval for Salerno Pharmaceuticals' liquid simvastatin oral suspension, citing missing annual reports.

Nov 17, 2026·3 sourcesStatinsFDA regulatory processLDL cholesterolDrug Policy, Pricing & Approval
FDA proposes to withdraw approval for Salerno's liquid cholesterol medication
00

Other sources for this story

Reuters

US FDA proposes to withdraw approval for Salerno's cholesterol medication | Reuters

MedPage Today

FDA Wants Liquid Statin Off Shelves